| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.28 | 3e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.27 | 6e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.31 | 7e-08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 2e-07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.14 | 0.009 |